Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 42,322 shares at $50.14 ($2.1M) on 2021-09-21, disclosed to the SEC on 2021-09-21.
Open-market sale of $2.1M CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.04 | 5,152 | $258K | 12.2% |
| 2 | $50.04 | 5,152 | $258K | 12.2% |
| 3 | $50.05 | 5,688 | $285K | 13.4% |
| 4 | $50.05 | 5,688 | $285K | 13.4% |
| 5 | $50.13 | 4,988 | $250K | 11.8% |
| 6 | $50.13 | 4,988 |
| $250K |
| 11.8% |
| 7 | $50.14 | 5,333 | $267K | 12.6% |
| 8 | $50.14 | 5,333 | $267K | 12.6% |
| Total | $50.09 avg | 42,322 | $2.1M | 100% |
| Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |
| CCCC | SELL | 2021-08-05 | $1.3M | — | Filing → |